ÂÜÀòÂÒÂ×

Zhenwu Luo is a seasoned scientist with extensive experience in drug development and molecular biology. Currently serving as a Senior Scientist at BioRay Pharmaceutical, Zhenwu focuses on ADC drug research and development for autoimmune diseases. Previously, Zhenwu held a Senior Scientist position at Sorrento Therapeutics, Inc., working on mRNA vaccine and circRNA platform construction, as well as identifying functional elements. Zhenwu's earlier roles include a Research Fellow at the Medical University of South Carolina, where research centered on autoantibodies and immune responses, and a Postdoctoral Researcher studying mRNA alternative splicing. Zhenwu also managed the Molecular Biology Research Department at Shanghai Hemo-pharmaceutical & Biological Co., Ltd., overseeing the lifecycle of molecular biology IVD products. Zhenwu holds a PhD in Biochemistry and Molecular Biology from the University of Chinese Academy of Sciences, a Master's degree in Molecular Microbiology from Peking Union Medical College, and a Bachelor's degree in Biotechnology from Wuhan University.